Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness (PG)

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2015 by Samsung Medical Center
Sponsor:
Information provided by (Responsible Party):
Doh Kwan Kim, Samsung Medical Center
ClinicalTrials.gov Identifier:
NCT00817011
First received: January 5, 2009
Last updated: December 30, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2018
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)